Novo Nordisk A/S – Share repurchase programme

NEXT STORY
Novartis announces EU approval of Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
PREV STORY
Capnography Devices Market Study, 2019-2025 – Rising Government Initiatives and Technological Advancements are Driving the Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OncoMed to Present Clinical Data for Anti-RSPO3 and Anti-DLL4/VEGF Bispecific Antibody at the 28th EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

REDWOOD CITY, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED) announced ...

author_avatar
NASDAQ Market News

Agios to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019

CAMBRIDGE, Mass., Dec. 28, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader ...

author_avatar
NASDAQ Market News

Dr. Richard D. Katz Joins Argos Therapeutics as Chief Financial Officer

DURHAM, N.C., July 11, 2016 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), an immuno-oncology ...

author_avatar
NASDAQ Market News